Literature DB >> 15383179

Generation of a mouse expressing a conditional knockout of the hepatocyte growth factor gene: demonstration of impaired liver regeneration.

Daniel Phaneuf1, A David Moscioni, Cynthia LeClair, Steven E Raper, James M Wilson.   

Abstract

Hepatocyte growth/scatter factor (HGF/SF) is a pleiotropic cytokine originally identified as a potent mitogen for rat hepatocytes. Two HGF/SF knockout mouse models have been reported, both of which exhibit developmental abnormalities causing embryonic lethality. To circumvent this limitation, we created a mouse conditionally deficient in liver expression of HGF/SF to specifically investigate the role of this mitogen in the process of adult liver regeneration. Gene targeting technology was used to generate a mouse with loxP sites flanking exon 5 of the HGF/SF gene (ex5-flox). In the absence of cre recombinase activity, mice homozygous for ex5-flox were indistinguishable from wild-type littermates. To ablate HGF/SF gene expression in vitro, primary hepatocytes established from homozygous HGF(ex5-flox) mice were infected with a recombinant adenoviral vector coding for cre recombinase (AdCre1). PCR analyses of genomic DNA demonstrated greater than 90% ablation of the ex5-floxed gene sequence. In vivo, HGF(ex.5-flox) mice were administered AdCre1 vector and the ablation of the HGF gene confirmed by Southern blot analysis. To induce liver regeneration, mice were injected with the hepatotoxin carbon tetrachloride. The regenerative capacity of hepatocytes in mice administered cre recombinase was shown to be significantly reduced when compared with mice injected with an adenovirus expressing LacZ. A similar reduction in hepatocyte regeneration was observed in HGF(ex.5.flox) mice carrying the cre transgene under the control of the interferon-inducible (pI:pC) Mx1 promoter, as an alternative strategy to ablate the HGF/SF gene in liver. Our results confirm the mitogenic role of HGF/SF in liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383179     DOI: 10.1089/dna.2004.23.592

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  16 in total

1.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice.

Authors:  Toshiyuki Otsuka; Norio Horiguchi; Daisuke Kanda; Takashi Kosone; Yuichi Yamazaki; Kazuhisa Yuasa; Naondo Sohara; Satoru Kakizaki; Ken Sato; Hitoshi Takagi; Glenn Merlino; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  Promise and challenges on the horizon of MET-targeted cancer therapeutics.

Authors:  Yu-Wen Zhang
Journal:  World J Biol Chem       Date:  2015-05-26

4.  Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.

Authors:  Jens U Marquardt; Daekwan Seo; Luis E Gómez-Quiroz; Koichi Uchida; Matthew C Gillen; Mitsuteru Kitade; Pal Kaposi-Novak; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Biochim Biophys Acta       Date:  2012-02-22

5.  Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration.

Authors:  Andrew J Lutkewitte; George G Schweitzer; Stefanie Kennon-McGill; Melissa M Clemens; Laura P James; Hartmut Jaeschke; Brian N Finck; Mitchell R McGill
Journal:  Food Chem Toxicol       Date:  2018-03-11       Impact factor: 6.023

6.  Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro.

Authors:  Gaelle del Castillo; Valentina M Factor; Margarita Fernández; Alberto Alvarez-Barrientos; Isabel Fabregat; Snorri S Thorgeirsson; Aránzazu Sánchez
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

7.  Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.

Authors:  Julie M Schultz; Shaheen N Khan; Zubair M Ahmed; Saima Riazuddin; Ali M Waryah; Dhananjay Chhatre; Matthew F Starost; Barbara Ploplis; Stephanie Buckley; David Velásquez; Madhulika Kabra; Kwanghyuk Lee; Muhammad J Hassan; Ghazanfar Ali; Muhammad Ansar; Manju Ghosh; Edward R Wilcox; Wasim Ahmad; Glenn Merlino; Suzanne M Leal; Sheikh Riazuddin; Thomas B Friedman; Robert J Morell
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

Review 8.  MET: a critical player in tumorigenesis and therapeutic target.

Authors:  Carrie R Graveel; David Tolbert; George F Vande Woude
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

9.  Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.

Authors:  Atul R Chopra; Jean-Francois Louet; Pradip Saha; Jie An; Franco Demayo; Jianming Xu; Brian York; Saul Karpen; Milton Finegold; David Moore; Lawrence Chan; Christopher B Newgard; Bert W O'Malley
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728

10.  Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts.

Authors:  Sonakshi Bhattacharjee; Florian Hamberger; Aashreya Ravichandra; Maximilian Miller; Ajay Nair; Silvia Affo; Aveline Filliol; LiKang Chin; Thomas M Savage; Deqi Yin; Naita Maren Wirsik; Adam Mehal; Nicholas Arpaia; Ekihiro Seki; Matthias Mack; Di Zhu; Peter A Sims; Raghu Kalluri; Ben Z Stanger; Kenneth P Olive; Thomas Schmidt; Rebecca G Wells; Ingmar Mederacke; Robert F Schwabe
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.